These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8542652)

  • 1. Comparison between serum levels of bone alkaline phosphatase and the carboxy-terminal propeptide of type I procollagen as markers of bone formation in patients following renal transplantation.
    Withold W; Degenhardt S; Grabensee B; Reinauer H
    Clin Chim Acta; 1995 Aug; 239(2):143-51. PubMed ID: 8542652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery.
    Minisola S; Romagnoli E; Scarnecchia L; Rosso R; Pacitti MT; Scarda A; Mazzuoli G
    Eur J Endocrinol; 1994 Jun; 130(6):587-91. PubMed ID: 8205259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of circulating C-terminal propeptide of type I procollagen in patients with chronic renal failure pre and post renal transplantation.
    Bonnin MR; Gonzalez MT; Griñó JM; Cruzado JM; Martínez JM; Navarro MA
    Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):897-900. PubMed ID: 8960463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
    Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of procollagen type I carboxyterminal extension peptide in cancer patients with bone metastases.
    Santi I; Monti M; Viganò A; D'Aprile E; Rampoldi E; Castellani L; Accinni R; Cunietti E
    Int J Biol Markers; 1995; 10(2):107-12. PubMed ID: 7561234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.
    Legovini P; De Menis E; Da Rin G; Roiter I; Breda F; Artuso V; Di Virgilio R; Conte N
    Horm Metab Res; 1994 Jul; 26(7):334-7. PubMed ID: 7959610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum propeptides of type I and III procollagens in renal transplant recipients. A comparison of cyclosporine and azathioprine treatment.
    Heickendorff L; Frost L; Madsen JK; Pedersen EB
    Nephron; 1994; 67(2):203-8. PubMed ID: 8072610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of osteoblast activity with an immunoradiometric assay for determination of bone alkaline phosphatase mass concentration in patients receiving renal transplants.
    Withold W; Degenhardt S; Castelli D; Heins M; Grabensee B
    Clin Chim Acta; 1994 Mar; 225(2):137-46. PubMed ID: 8088003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of bone metabolism after bone marrow transplantation by measuring two different markers of bone turnover.
    Withold W; Wolf HH; Kollbach S; Heyll A; Schneider W; Reinauer H
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):193-7. PubMed ID: 8721406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of carboxyterminal propeptide of type I procollagen in haemodialysis patients.
    Sawamura T; Sasagawa I; Kubota Y; Ishigooka M; Nakada T; Adachi M; Yamaguchi T
    Int Urol Nephrol; 1998; 30(1):99-103. PubMed ID: 9569120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone formation in the study of postmenopausal osteoporosis.
    Dominguez Cabrera C; Sosa Henríquez M; Traba ML; Alvarez Villafañe E; de la Piedra C
    Osteoporos Int; 1998; 8(2):147-51. PubMed ID: 9666938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.
    Joffe P; Heaf JG; Jensen LT
    Nephrol Dial Transplant; 1995 Oct; 10(10):1912-7. PubMed ID: 8592603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age related changes in biochemical markers of bone metabolism in horses.
    Price JS; Jackson B; Eastell R; Goodship AE; Blumsohn A; Wright I; Stoneham S; Lanyon LE; Russell RG
    Equine Vet J; 1995 May; 27(3):201-7. PubMed ID: 7556047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure.
    Franke S; Lehmann G; Abendroth K; Hein G; Stein G
    Eur J Med Res; 1998 Feb; 3(1-2):81-8. PubMed ID: 9512973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases.
    Ebeling PR; Peterson JM; Riggs BL
    J Bone Miner Res; 1992 Nov; 7(11):1243-50. PubMed ID: 1466250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.